Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02727842 · ClinicalTrials.gov registry record · NA
Usability of the CP950 Sound Processor
A NA study, sponsored by Cochlear.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT02727842: Completed NA study, sponsored by Cochlear.
NCT02727842 is a NA study that has completed, run by Cochlear. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02727842, a NA study, has completed, sponsored by Cochlear.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
Studying usability and gaining feedback of the CP950 Sound Processor in experienced cochlear implant recipients.
Primary Outcome
To evaluate usability of the CP950 sound processor using the CP950 Take Home Questionnaire for existing cochlear implant users. Specifically: 1. Patient Reported Hearing Performance 2. Retention \& Comfort 3. Ease of use 4. Use of remote controls 5. Look \& feel 6. Reliability 7. Maintenance \& use
Interventions
- DEVICE CP950 Sound Processor
- DEVICE Wireless programming pod
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2016-04 |
| Est. Completion | 2016-12 |
| Phase | NA |
What the finished NCT02727842 record still lists
NCT02727842 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which CP950 Sound Processor is the first listed.
NCT02727842 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02727842 about?
NCT02727842 is a clinical study titled "Usability of the CP950 Sound Processor". Studying usability and gaining feedback of the CP950 Sound Processor in experienced cochlear implant recipients.
What is the current status of trial NCT02727842?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2016-04. Estimated completion is 2016-12.
What interventions are being tested in trial NCT02727842?
The interventions under investigation include: CP950 Sound Processor (DEVICE), Wireless programming pod (DEVICE).
Who is sponsoring clinical trial NCT02727842?
This trial is sponsored by Cochlear, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02727842's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia